Laboratory Corp. of America Holdings Company Profile (NYSE:LH)

Analyst Ratings

Consensus Ratings for Laboratory Corp. of America Holdings (NYSE:LH) (?)
Ratings Breakdown: 6 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $134.82 (2.88% downside)

Analysts' Ratings History for Laboratory Corp. of America Holdings (NYSE:LH)
Show:
DateFirmActionRatingPrice TargetActions
6/9/2016Credit Suisse Group AGReiterated RatingOutperform$135.00 -> $143.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2016KeyCorpReiterated RatingBuy$143.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Robert W. BairdReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016Jefferies GroupBoost Price TargetHold$121.00 -> $131.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016Canaccord GenuityBoost Price TargetBuy$135.00 -> $140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016Barclays PLCBoost Price TargetOverweight$152.00 -> $155.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016MizuhoBoost Price TargetNeutral$119.00 -> $132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016Goldman Sachs Group Inc.Boost Price Target$119.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/4/2016William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2016Deutsche Bank AGLower Price TargetHold$134.00 -> $121.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/19/2016Royal Bank Of CanadaLower Price TargetSector Perform$135.00 -> $130.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/16/2016SunTrust Banks Inc.Lower Price TargetBuy$145.00 -> $134.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Raymond James Financial Inc.Lower Price TargetOutperform$145.00 -> $135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2015JPMorgan Chase & Co.Boost Price TargetOverweight$141.00 -> $144.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015JMP SecuritiesInitiated CoverageOutperform$165.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/24/2015Maxim GroupBoost Price TargetBuy$141.00 -> $160.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015Cantor FitzgeraldSet Price TargetBuy$115.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Wells Fargo & Co.Initiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2015Piper Jaffray Cos.UpgradeNeutral -> Overweight$113.00 -> $140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2015Evercore ISIUpgradeHold -> Buy$105.00 -> $132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015Citigroup Inc.UpgradeNeutral -> Buy$114.00 -> $132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/29/2014FBR & CoReiterated RatingMarket Perform$106.00 -> $112.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Laboratory Corp. of America Holdings (NYSE:LH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/27/2016ListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2016Q116$1.96$2.02$2.19 billion$2.30 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/18/2016Q415$1.99$1.98$2.22 billion$2.24 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/26/2015Q315$2.07$2.07$2.25 billion$2.30 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q215$2.03$2.09$2.22 billion$2.20 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2015Q115$1.63$1.73$1.79 billion$1.80 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/20/2015Q4$1.63$1.65$1.51 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2014Q3$1.75$1.80$1.56 billion$1.55 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/18/2014Q214$1.77$1.84$1.50 billion$1.52 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2014Q114$1.58$1.51$1.45 billion$1.43 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/7/2014Q413$1.66$1.61$1.46 billion$1.44 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/18/2013Q313$1.80$1.80$1.45 billion$1.46 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/19/2013Q2 2013$1.80$1.80$1.46 billion$1.47 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2013Q1 2013$1.77$1.74$1.45 billion$1.44 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/8/2013Q4 2012$1.62$1.54$1.39 billion$1.41 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/18/2012$1.74$1.76ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/19/2012$1.76$1.77ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/19/2012$1.67$1.74ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2012$1.41$1.46ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/20/2011$1.50$1.61ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/21/2011$1.53$1.64ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/21/2011$1.46$1.52ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2011$1.31$1.34ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Laboratory Corp. of America Holdings (NYSE:LH)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20169$1.95$2.05$1.98
Q2 20165$2.28$2.39$2.31
Q3 20166$2.28$2.38$2.31
Q4 20166$2.15$2.26$2.20
Q1 20171$2.15$2.15$2.15
Q2 20171$2.53$2.53$2.53
Q3 20171$2.55$2.55$2.55
Q4 20171$2.46$2.46$2.46
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Laboratory Corp. of America Holdings (NYSE:LH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Laboratory Corp. of America Holdings (NYSE:LH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/13/2016David P KingCEOSell196,400$128.00$25,139,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/27/2016Edward T DodsonInsiderSell9,392$126.42$1,187,336.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2016F Samuel Eberts IIIInsiderSell4,219$116.85$492,990.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2016James T Jr. BoyleCEOSell18,132$116.81$2,117,998.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016F Samuel Eberts IIIInsiderSell309$115.32$35,633.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016James T Jr. BoyleCEOSell1,543$115.32$177,938.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2016Jean-Luc BelingardDirectorSell1,296$109.74$142,223.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016F Samuel Eberts IIIInsiderSell370$103.02$38,117.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/16/2016James T. Jr. BoyleCEOSell4,055$103.02$417,746.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016F Samuel Eberts IIIinsiderSell405$101.67$41,176.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2016James T. Jr. BoyleCEOSell2,712$101.67$275,729.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2016F Samuel Eberts IIIInsiderSell1,215$119.05$144,645.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015F Samuel Eberts IIIInsiderSell1,010$123.31$124,543.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015R Sanders WilliamsDirectorSell1,850$124.30$229,955.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015David P KingCEOSell50,000$121.78$6,089,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Jean-Luc BelingardDirectorSell1,542$123.10$189,820.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/23/2015James T Jr. BoyleCEOSell1,394$126.56$176,424.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/31/2015Mark E BrecherCMOSell20,625$126.98$2,618,962.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/30/2015Mark E BrecherCMOSell20,278$126.98$2,574,900.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015James T Jr. BoyleCOOSell1,237$123.70$153,016.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015James T Jr. BoyleCOOSell6,597$116.68$769,737.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/22/2014David P KingCEOSell65,234$104.71$6,830,652.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014R Sanders WilliamsDirectorSell2,000$107.95$215,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/22/2014David P KingCEOSell65,233$106.10$6,921,221.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/22/2014David P KingCEOSell65,233$105.55$6,885,343.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2014James T Jr. BoyleCOOSell38,600$103.00$3,975,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2014M Keith WeikelDirectorSell1,984$98.28$194,987.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/28/2014James Jr. BoyleCOOSell2,521$98.36$247,965.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2014William HayesCFOSell23,848$94.40$2,251,251.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2014James Jr. BoyleCOOSell4,123$90.29$372,265.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014James Jr. BoyleCOOSell1,204$91.15$109,744.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2014David KingCEOSell24,200$90.15$2,181,630.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2013David KingCEOSell25,000$90.79$2,269,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2013David P KingCEOSell25,000$100.91$2,522,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/17/2013James T Jr. BoyleCOOSell24,400$102.00$2,488,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/25/2013David KingCEOSell25,000$99.06$2,476,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013David KingCEOSell25,000$96.60$2,415,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2013Robert Mittelstaedt, Jr.DirectorSell7,429$96.86$719,572.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2013David P KingCEOSell25,000$97.72$2,443,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2013David P KingCEOSell25,000$98.66$2,466,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/7/2013James T Jr. BoyleCOOSell63,100$99.63$6,286,653.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Mark E BrecherInsiderSell16,900$100.92$1,705,548.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2013William B HayesCFOSell127,200$100.00$12,720,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013F Samuel Eberts IIIInsiderSell10,000$98.47$984,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013James T Jr. BoyleCOOSell68,908$93.82$6,464,948.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2013Jean-Luc BelingardDirectorSell2,536$92.88$235,543.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/11/2013William B HayesCFOSell22,234$95.00$2,112,230.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Laboratory Corp. of America Holdings (NYSE:LH)
DateHeadline
07/24/16 04:32 PMIs $160 Price Target Attainable For Laboratory Corporation of America Holdings (NYSE:LH)? - Investor Newswire
07/22/16 10:16 AMBet on These 5 Stocks Registering Strong Sales Growth -
07/20/16 02:30 PMWally Weitz Comments on Laboratory Corp of America -
07/20/16 07:54 AMLabCorp: Clinical Gains
07/20/16 07:54 AMTransgenomic Licenses Commercial Rights to Its Long QT Syndrome DNA Testing Portfolio to LabCorp
07/19/16 05:02 PMStock Positive on the Year: Laboratory Corp. of America Holdings (NYSE:LH) - TGP
07/19/16 05:02 PMStock Check-In at the Close: Laboratory Corp. of America Holdings (NYSE:LH) - TGP
07/19/16 05:02 PMLaboratory Corporation of America Holdings (NYSE:LH): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/18/16 05:06 PMAnalysts Pounding the Table on Shares of Laboratory Corp. of America Holdings (NYSE:LH) - TGP
07/18/16 05:06 PMLarge Cap Medical Laboratories & Research: Laboratory Corp. of America Holdings (NYSE:LH) - Twin County News
07/18/16 05:06 PMLaboratory Corporation of America Holdings (NYSE:LH) Expected To Post Sales Of $10102.276 - Investor Newswire
07/18/16 02:27 PMWill LabCorp (LH) Beat Earnings Estimates in Q2? -
07/17/16 04:28 PMStrong Sell Calls For Laboratory Corporation of America Holdings (NYSE:LH) At 0 - Investor Newswire
07/17/16 09:16 AMVisium Asset Management LP Decreased Stake in Laboratory Corp Of America Holdings (NYSE:LH) by $43.29 Million ... - Consumer Eagle
07/17/16 09:16 AMStock in Positive Territory for the Quarter: Laboratory Corp. of America Holdings (NYSE:LH) - Engelwood Daily
07/17/16 09:16 AMLaboratory Corp. of America Holdings Realized Volatility Hits Extremely Low Level - CML News
07/15/16 09:03 AMInsiders are Gradually Selling Laboratory Corp. of America Holdings (NYSE:LH) - Telanagana Press
07/15/16 09:03 AMInstitutions are Increasing Positions in Laboratory Corp. of America Holdings (NYSE:LH) - Engelwood Daily
07/15/16 09:03 AMPrior Trading Session Wrap-Up: Laboratory Corp. of America Holdings (NYSE:LH) - Press Telegraph
07/13/16 05:20 PMHealthcare Sector Equities Under the Scanner -- Agilent Technologies, Biogen, Quest Diagnostics, and Laboratory Corp. of America Holdings
07/11/16 04:58 PMStock Performance Rundown on: Laboratory Corp. of America Holdings (NYSE:LH) - Press Telegraph
07/11/16 04:58 PMNext Weeks Broker Price Targets For Laboratory Corporation Of America Holdings (NYSE:LH) - Fiscal Standard
07/11/16 04:58 PMIs $160 Within Reach For Laboratory Corporation of America Holdings (NYSE:LH)? - Investor Newswire
07/11/16 04:58 PMCompany Shares of Laboratory Corporation of America Holdings (NYSE:LH) Rally 3.05% - TheFounders Daily
07/11/16 04:58 PMLaboratory Corp of America Holdings (NYSE:LH) Shined on Trading Terminals - Street Report
07/08/16 05:02 PMShares Moving to a Recent High: Laboratory Corp. of America Holdings (NYSE:LH) - Press Telegraph
07/08/16 05:02 PMLaboratory Corp. of America Holdings (NYSE:LH) – Top Stock from Healthcare Sector - The Daily Leicester
07/08/16 07:51 AMPrevious Trading Session Wrap-Up: Laboratory Corp. of America Holdings (NYSE:LH) - Press Telegraph
07/07/16 04:59 PMWill Laboratory Corporation of America Holdings (NYSE:LH) Surprise Analysts This Quarter? - Stocks Daily
07/07/16 04:59 PMStock Setting a Recent High: Laboratory Corp. of America Holdings (NYSE:LH) - Press Telegraph
07/07/16 07:53 AMStock Strength Recap for Laboratory Corp. of America Holdings (NYSE:LH) - Press Telegraph
07/07/16 07:53 AMHow has Laboratory Corp. of America Holdings:(NYSE:LH) performed recently? - The Daily Leicester
07/05/16 04:47 PMCooke & Bieler LP Decreased Stake in Laboratory Corp. Of America (NYSE:LH) by $6.05 Million as Shares Declined - Press Telegraph
07/05/16 04:47 PMInstitution Favorite: Laboratory Corp. of America Holdings (NYSE:LH) - Telanagana Press
07/05/16 04:47 PMCompany Stock Focus for Laboratory Corporation of America Holdings (NYSE:LH): Which Way Will Shares Head? - Press Telegraph
07/05/16 04:47 PMLeading stocks in today's market: Laboratory Corp. of America Holdings (NYSE:LH) - Twin County News
07/04/16 09:46 AMLaboratory Corporation of America Holdings (NYSE:LH) Expected to Reach Highs Of $160 - Investor Newswire
07/04/16 09:46 AMHow Analysts Rated Laboratory Corp. of America Holdings (NYSE:LH) Last Week? - Press Telegraph
07/02/16 04:43 PMStock Valuation in Review: Laboratory Corp. of America Holdings (NYSE:LH) - Telanagana Press
07/02/16 04:43 PMLaboratory Corporation of America Holdings (NYSE:LH): The Buzzing Stock - Stocks Daily
07/01/16 04:56 PMConversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
07/01/16 08:11 AMConversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021 - [at noodls] - BURLINGTON, N.C.--(BUSINESS WIRE)--Jul. 1, 2016-- Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon ...
07/01/16 07:55 AMLABORATORY CORP OF AMERICA HOLDINGS Files SEC form 8-K, Regulation FD Disclosure -
06/27/16 08:31 AMLabCorp Announces Launch of New Companion Diagnostic for Non-Small Cell Lung Cancer - [at noodls] - The Rochecobas EGFR Mutation Test v2 is the First Blood-Based Liquid Biopsy Test Approved by FDA for Clinical Use BURLINGTON, N.C.--(BUSINESS WIRE)--Jun. 27, 2016-- Laboratory Corporation of AmericaHoldings ...
06/26/16 04:17 PMStock Performance Focus on: Laboratory Corp. of America Holdings (NYSE:LH) - Press Telegraph
06/24/16 07:35 AMLaboratory Corp of America Holdings (NYSE:LH) Shined on Trading Screens - Street Report
06/24/16 07:35 AMPrice Target Update on Laboratory Corporation of America Holdings (NYSE:LH) - Trade Calls
06/22/16 09:35 AMStocks Buzz: AFLAC Incorporated (NYSE:AFL), Laboratory Corp. of America Holdings (NYSE:LH) - NYSE Journal (press release)
06/22/16 09:35 AMAnalyst Review Alert: Laboratory Corp. of America Holdings (NYSE:LH) - iStreetWire
06/21/16 04:36 PMLaboratory Corporation of America Holdings (NYSE:LH) Yearly Sales Projections At $10046.94 - Investor Newswire

Social

About Laboratory Corp. of America Holdings

Laboratory Corp. of America Holdings logoLaboratory Corporation of America Holdings is a healthcare diagnostics company. The Company, together with its subsidiaries, is engaged in providing clinical laboratory services and drug development support. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The Company's LCD segment is an independent clinical laboratory business that consists of a network of approximately 40 primary laboratories and approximately 1,700 patient service centers (PSCs) along with a network of branches and STAT laboratories, which offer a menu of routine and frequently ordered tests. LCD offers a menu of over 4,700 tests, such as blood chemistry analyses, urinalyses, blood cell counts and thyroid tests. Its CDD segment offers drug development services, and provides a range of drug development solutions across the world, primarily to companies in the pharmaceutical and biotechnology industries.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Health Care Services
  • Exchange: NYSE
  • Symbol: LH
  • CUSIP: 50540R40
Key Metrics:
  • Previous Close: $138.82
  • 50 Day Moving Average: $131.53
  • 200 Day Moving Average: $120.37
  • P/E Ratio: 24.08
  • P/E Growth: 1.56
  • Market Cap: $14.22B
  • Beta: 0.88
  • Current Year EPS Consensus Estimate: $8.79 EPS
  • Next Year EPS Consensus Estimate: $9.72 EPS
Additional Links:
Laboratory Corp. of America Holdings (NYSE:LH) Chart for Monday, July, 25, 2016